ATE534397T1 - Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien - Google Patents

Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien

Info

Publication number
ATE534397T1
ATE534397T1 AT05732131T AT05732131T ATE534397T1 AT E534397 T1 ATE534397 T1 AT E534397T1 AT 05732131 T AT05732131 T AT 05732131T AT 05732131 T AT05732131 T AT 05732131T AT E534397 T1 ATE534397 T1 AT E534397T1
Authority
AT
Austria
Prior art keywords
dmbt1
accessible
phosphate groups
sulfate
capture agents
Prior art date
Application number
AT05732131T
Other languages
English (en)
Inventor
Jan Mollenhauer
Caroline End
Stephanie Blaich
Gaby Bergmann
Marcus Renner
Stefan Lyer
Rainer Wittig
Annemarie Poustka
Floris Bikker
Antoon Ligtenberg
Arie Nieuw-Amerongen
Enno Veerman
Original Assignee
Jan Mollenhauer
Stefan Lyer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Jan Mollenhauer, Stefan Lyer filed Critical Jan Mollenhauer
Application granted granted Critical
Publication of ATE534397T1 publication Critical patent/ATE534397T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569—Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911—Bacteria
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10T—TECHNICAL SUBJECTS COVERED BY FORMER US CLASSIFICATION
    • Y10T436/00—Chemistry: analytical and immunological testing
    • Y10T436/14—Heterocyclic carbon compound [i.e., O, S, N, Se, Te, as only ring hetero atom]
    • Y10T436/142222—Hetero-O [e.g., ascorbic acid, etc.]
    • Y10T436/143333—Saccharide [e.g., DNA, etc.]

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Hematology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Epidemiology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • Food Science & Technology (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Marine Sciences & Fisheries (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Cell Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Oncology (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
AT05732131T 2004-02-25 2005-02-25 Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien ATE534397T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP04004281A EP1568374A1 (de) 2004-02-25 2004-02-25 Verwendung von DMBT1 zur Bindung von Slfat- und Phosphatgruppen aufweisenden Substanzen
PCT/EP2005/001994 WO2005079834A1 (en) 2004-02-25 2005-02-25 Use of dmbt1 for capturing sulphate and phosphate group exposing agents

Publications (1)

Publication Number Publication Date
ATE534397T1 true ATE534397T1 (de) 2011-12-15

Family

ID=34745899

Family Applications (1)

Application Number Title Priority Date Filing Date
AT05732131T ATE534397T1 (de) 2004-02-25 2005-02-25 Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien

Country Status (4)

Country Link
US (1) US8017124B2 (de)
EP (2) EP1568374A1 (de)
AT (1) ATE534397T1 (de)
WO (1) WO2005079834A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2015106084A1 (en) * 2014-01-09 2015-07-16 Uab Research Foundation Compositions that inhibit and prevent the formation of dental caries and methods of using the same
EP4009049A1 (de) 2020-12-01 2022-06-08 Friedrich-Alexander-Universität Erlangen-Nürnberg Immobilisierung und magnetische extraktion von pathogenen und pathogenkomponenten

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1998030687A2 (de) * 1997-01-09 1998-07-16 Deutsches Krebsforschungszentrum Stiftung des öffentlichen Rechts Srcr domäne-enthaltendes protein
US6287605B1 (en) * 1998-04-17 2001-09-11 The Trustees Of The University Of Pennsylvania Compositions and methods useful in treatment and prevention of HIV-1 infection

Also Published As

Publication number Publication date
EP1568374A1 (de) 2005-08-31
WO2005079834A9 (en) 2005-10-27
WO2005079834A1 (en) 2005-09-01
EP1727558A1 (de) 2006-12-06
EP1727558B1 (de) 2011-11-23
US8017124B2 (en) 2011-09-13
US20080234185A1 (en) 2008-09-25

Similar Documents

Publication Publication Date Title
Wachtel et al. Self-injury in autism as an alternate sign of catatonia: implications for electroconvulsive therapy
ATE470151T1 (de) Diagnose, behandlung und prävention von gefässerkrankungen mittels il-1alpha- autoantikörpern
ATE551350T1 (de) Verfahren und reagenzien zur behandlung und diagnose von gefässerkrankungen und altersbedingter makuladegeneration
TW200736252A (en) Novel heteroaryl substituted benzothiazoles
ATE446102T1 (de) Behandlung von gewichtsverlust bei patienten mit entzündlichen darmerkrankungen mittels s. boulardii
WO2007059064A3 (en) Fgf2-related methods for diagnosing and treating depression
MY147347A (en) Novel 2-heteroaryl substituted benzothiophenes and benzofuranes
DE60122673D1 (de) Methoden zur diagnose und behandlung von herzkrankheiten
WO2010051196A8 (en) Novel substituted azabenzoxazoles
ATE534397T1 (de) Verwendung von dmbt1 zum einfangen von sulfat- und phosphatgruppen exponierenden agenzien
BR0314713A (pt) Processos e reagentes para o tratamento de doenças e distúrbios associados com nìveis aumentados de citocinas pró-inflamatórias
DE602007006284D1 (de) Verfahren zur vorhersage des ansprechens von patienten mit multipler sklerose auf eine interferontherapie und zur diagnose von multipler sklerose
DE60037126D1 (de) POLYMORPHISMEN DES MENSCHLICHEN HPXR Gens UND IHRE ANWENDUNG IN DIAGNOSE UND THERAPIE
DE602006019759D1 (de) Sulfatide zur behandlung von autoimmunkrankheiten
DE602004027613D1 (de) Therapeutische, prophylaktische und diagnostische wirkstoffe
Semakova et al. Neuropsychological approach to the organization of assistance to family, which raising child with autism disorders
AR056831A1 (es) Metodo para el diagnostico y tratamiento de enfermedades cardiovasculares
ATE554790T1 (de) Verfahren und zusammensetzungen zur diagnose von asthma
UA14435U (en) Method for assessing rehabilitation potential in disabled persons with cardiologic pathology
WO2015070084A3 (en) Nuclear stress response in motor neuron disease and other neurological diseases
ATE390435T1 (de) Zusammensetzungen und verfahren zur diagnose und behandlung von diabetes, insulinresistenz und dyslipidämie
Selvaraj 0042 PERFORMANCE OF ADHESIVE WIRELESS PATCH SENSOR FOR SCREENING OF SLEEP ARCHITECTURE IN NORMAL AND APNEA
Prathap et al. Occupational allergic contact dermatitis: a clinical study in a tertiary care centre in central kerala
RU2648342C1 (ru) Скрининговый метод выявления дефектных состояний при шизофрении
Allen Sepsis in the Time of COVID-19